Picture of SyntheticMR AB (publ) logo

SYNT SyntheticMR AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for SyntheticMR AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4.920.8659.997.2214.1
Depreciation
Non-Cash Items-0.326-2.441.5
Other Non-Cash Items
Changes in Working Capital4.44-13.8-9.92-25.2-28.8
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities12.8-8.934.35-15.2-6.96
Capital Expenditures-3.62-5.55-5.11-10.5-9.52
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1110.001-0.195
Other Investing Cash Flow
Cash from Investing Activities-3.62-5.55-5.22-10.5-9.71
Financing Cash Flow Items-5.350
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6.55-7.04-0.95753.7-1.01
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.66-21.7-1.4528.9-19.2